Clinical Trial Update: A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy study of a topical gel, N-Acetyl-GED-0507-34-LEVO Gel 5%, for acne vulgaris. Sponsored by PPM Services S.A., the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• N-Acetyl-GED-0507-34-LEVO Gel 5%

Snippet

Sponsor: PPM Services S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: ACTIVE_NOT_RECRUITING